THR-184

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameTHR-184
Drug Alias NameAA-184THR-184
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionBone morphogenetic protein receptor type I agonistsBone morphogenetic protein receptor type-2 agonists
TargetsBone morphogenetic protein receptor type-2Bone morphogenetic protein receptor type I
Therapy Area/IndicationsAcute Kidney Injury
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited States
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesThrasos Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesThrasos Innovation Inc
Active IndicationsN/A
Inactive IndicationsAcute Kidney Injury

Other Information

ATC CodeN/A
Related LinksN/A